| For: | Liu XX, Hassan W, Ahmed H, Song SZ. Hepatoprotective effects of silybin in liver fibrosis. World J Gastroenterol 2025; 31(42): 110449 [PMID: 41278156 DOI: 10.3748/wjg.v31.i42.110449] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v31/i42/110449.htm |
| Number | Citing Articles |
| 1 |
Zhe Jin, Jing Zhu, Binghong Lu, Yabo Li, Yan Chen. Phytochemical basis, multitarget pharmacology, and translational perspectives of silymarin: emphasis on its antifibrotic effects. Frontiers in Pharmacology 2026; 17 doi: 10.3389/fphar.2026.2001949
|
| 2 |
Ricardo Jair Ramírez-Carreto, Verónica Salas-Venegas, Vanelly De la Rosa-Hernández, Omar Noel Medina-Campos, Ulises Martínez-Ortega, Haydeé Torres-Guerrero, Francisco Hernández-Luis, José Pedraza-Chaverri, Mina Königsberg, Anahí Chavarría. Silybin attenuates PERK/IRE1α ER-stress signaling, neuroinflammation, and restores CDNF levels in an MPTP-induced Parkinson's disease model. European Journal of Pharmacology 2026; 1030 doi: 10.1016/j.ejphar.2026.179126
|
| 3 |
Fei Zhao, Anwei Wei, Zhenzhen Liu, Yipu Zhao, Bowei Liu. Ginsenoside Rh1 exerts hepatoprotective effects against liver fibrosis through induction of ferroptosis via SLC7A11 inhibition. The International Journal of Biochemistry & Cell Biology 2026; doi: 10.1016/j.biocel.2026.107056
|